Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery (Telehealth RCT)

May 15, 2026 updated by: University of Chicago

Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery: A Randomized Controlled Trial

Telehealth, or telemedicine, utilizes technology to deliver clinical care remotely, either in real time or asynchronously, between clinician and patient. Telemedicine has been successfully implemented to increase healthcare delivery for patients in rural areas with otherwise long travel times, and studies have also determined that telemedicine can increase patient satisfaction scores while simultaneously decreasing direct and indirect costs for patients.

Previous scholarship has demonstrated that telemedicine can be a safe alternative to face-to-face postoperative visits for surgical patients, streamlining recovery with no significant delays in the diagnosis of surgical complications. As healthcare systems continue to emphasize value-based care, it is important to assess whether virtual postoperative visits effectively meet patient needs while optimizing resource utilization.

Patient-reported outcomes and satisfaction surveys can help identify potential gaps in care and ensure that telehealth is implemented in a way to maximize both efficiency and quality. Our primary objective is to determine whether patient satisfaction with postoperative telehealth follow-up is non-inferior to in-person clinic visits.

Study Overview

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60637
        • University of Chicago
        • Contact:
      • Hinsdale, Illinois, United States, 60521
        • UChicago Medicine Advent Hinsdale
        • Principal Investigator:
          • Laura Douglass, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Women over the age of 18 and scheduled for a minimally invasive gynecologic surgery (laparoscopic or robotic surgeries including: excision of endometriosis, adnexal surgery with oophorectomy or cystectomy, myomectomy, or hysterectomy.)

Description

Inclusion Criteria:

  1. Participant has provided written informed consent.
  2. Women over the age of 18.
  3. Ability for patients to complete telehealth visits (i.e. working telephone or internet access) and speak and understand English.
  4. Laparoscopic or robotic surgeries including: excision of endometriosis, adnexal surgery with oophorectomy or cystectomy, myomectomy, and hysterectomy.
  5. Undergoing minimally invasive gynecologic surgeries with complex pelvic surgeons (AAGL fellowship-trained).

Exclusion Criteria:

  1. Conversion to open surgery.
  2. Malignancy noted intraoperatively or on final pathology evaluation.
  3. Surgeon or patient preference for in person clinic follow up.
  4. Pregnancy - pregnancy tests will be completed as part of routine preoperative care on the day of surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
control group
in person clinic visits
experimental group
virtual visits ((telephone or video)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction with surgery and postoperative visits
Time Frame: 3 months
Satisfaction scores will be compiled from participant responses to the Surgical-Consumer Assessment of Healthcare Providers and Systems (S-CAHPS) questionnaire. This questionnaire was developed by the American College of Surgeons and includes seven composites: (1) information to help prepare for surgery, (2) surgeon communication preoperatively, (3) surgeon attentiveness on the day of surgery, (4) information to help during recovery, (5) surgeon communication after surgery, (6) qualities of office staff, and (7) an overall surgeon rating. Specific attention will be paid to participant ratings of items 4, 5, and 7.
3 months
Patient satisfaction with virtual care delivery
Time Frame: 3 months
Satisfaction scores will be compiled from responses to the Telehealth Usability Questionnaire (TUQ): a validated tool of 21 questions used to assess patients' and providers' perceptions of telehealth systems. It evaluates domains such as ease of use, interface quality, interaction quality, reliability, and overall satisfaction, providing a structured way to measure and improve telehealth user experience (graded on a 5-point Likert scale).
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Additional healthcare utilization and adverse events
Time Frame: 3 months
Patient safety will be gauged by proxy via measurement of additional healthcare utilization by participants during the follow-up interval; specifically, the number of hospital re-admissions, emergency department or urgent care visits, and unscheduled clinic visits. Additionally, incidence of reoperation, blood transfusion, and wound infections will be tracked.
3 months
Incidence of common postoperative outcomes
Time Frame: 3 months
Clinical outcomes will be evaluated by a standardized institutional postoperative questionnaire which queries patients about common postoperative symptoms including return of bowel function, return of appetite, use of additional pain medications, fevers, and vaginal bleeding.
3 months
Postoperative pain
Time Frame: 3 months
Pain scores will be tabulated using the Short-form McGill Pain Questionnaire 2
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Douglass, MD, University of Chicago

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

January 7, 2026

First Submitted That Met QC Criteria

February 11, 2026

First Posted (Actual)

February 19, 2026

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 15, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No current plan to share data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe